Advances in surgical therapy for HCC 

Chairs:

1. Parissa Tabrizian, Board-certified surgeon in hepatobiliary and liver transplantation at the Recanati/Miller Transplantation Institute. Pprofessor of surgery at the Mount Sinai School of Medicine. , New York, USA
2. Vatche Agopian,Associate Professor of Surgery and Director of the Dumont-UCLA Liver Cancer Center at the David Geffen School of Medicine at UCLA, Los Angeles, USA

Topics and Speakers:

1. Expanded HCC downstaging criteria for liver transplantation, Anjana Pillai, Associate Professor of Medicine Co-Director, Living Donor Liver Transplant Program. Medical Director, Liver Tumor Program. Director, Transplant Hepatology Fellowship Program, The University of Chicago Medicine, Chicago, USA

1. Neoadjuvant and adjuvant immunotherapy for HCC, David Pinato,Clinician Scientist and Consultant Medical Oncologist, Department of Surgery and Cancer at Imperial College, London. UK

2. Advances in minimally invasive surgical resection for HCC,Fabrizio Di Benedetto, Associate Professor of Surgery, University of Modena and Reggio Emilia, Modena, Italy